Viewing Study NCT00557102


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-28 @ 6:32 PM
Study NCT ID: NCT00557102
Status: COMPLETED
Last Update Posted: 2012-12-11
First Post: 2007-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
Sponsor: National Cancer Institute, France
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: CDR0000574153
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View